Orion Oyj (OTCMKTS:ORINF) Short Interest Update

Orion Oyj (OTCMKTS:ORINF) was the recipient of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 383,900 shares, an increase of 35.3% from the March 15th total of 283,700 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Orion Oyj Price Performance

Shares of Orion Oyj stock traded up $0.86 on Friday, reaching $48.65. The business’s 50-day moving average is $48.63 and its 200-day moving average is $48.23. Orion Oyj has a 52 week low of $48.65 and a 52 week high of $48.65.

Orion Oyj Company Profile

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.